Overview

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

Status:
Terminated
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the efficacy and safety of IOP Injection (MPB-1514) for the treatment of iron-deficient anemia (IDA).
Phase:
Phase 2
Details
Lead Sponsor:
MegaPro Biomedical Co. Ltd.